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Diabetic Nephropathy S7Methods: Bring into the DKD patients through pathological diagnosis which
have more than one year disease course, to classify by the Tervaet criterion
of pathological stage of DKD, to differentiate the syndrome differentiation
in TCM by collecting clinical data, and have a statistical processing at last.
Results: We collected 353 DKD patients meeting the criterion in total, clas-
sified by the pathological stage criterion of DKD, among them there were 52
patients with phase I, 90 patients with phase IIa, 29 patients with phase
IIb,141 patients with phase III, 41 patients with phase IV. About syndrome
differentiation, there were 13 patients with Yin-Xu-Zao-Re type, there
were 151 patients with Qi-Yin-Liang-Xu type, there were 140 patients with
Pi-Shen-Qi-Xu type, there were 49 patients with Yin-Yang-Liang-Xu type,
there were 19 patients with Han-Shi type, there were 68 patients with Shi-
Re type, there were 212 patients with Yu-Xue type, there were 54 patients
with Tan-Yu type. In the patients with Yin-Xu-Zao-Re type, the renal inter-
stitial inflammation was more serious than other typs. In the patients with
Pi-Shen-Qi-Xu type, the glomerular segmental sclerosis, nodular changes,
and fibrinoid exudation were more serious than other groups. In the patients
with Yu-Xue syndrome differentiation, interstitial fibrosis and tubular atro-
phy (IFTA), interstitial inflammation, hyaline degeneration, angiosclerosis,
and fibrinoid exudation were more serious than other types significantly.
Multivariate COX analysis showed that syndrome differentiation were inde-
pendent risk factors for renal prognosis.
Conclusion: Among the syndrome differentiation of DKD, Qi-Yin-Liang-Xu
type and Yu-Xue type were more frequently than other tyes. The result
showed that syndrome differentiation was correlated significantly with path-
ological stage of DKD, Yin-Yang-Liang-Xu type and Tan-Yu type were inde-
pendent risk factors for renal prognosis in DKD.http://dx.doi.org/10.1016/j.hkjn.2015.08.0240096
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Objective: Diabetic nephropathy (DN) is one of the most severe microvascular
complications of diabetes. Recently, Berberine (BBR) has the beneficial effects
to diabetes. The aim of this study is to observe the renoprotective effect and
mechanisms of berberine in a type 2 diabetes nephropathy on rat.
Methods: Twenty seven male Wistar rats (8-wk old, 200e250 g) randomly
divided into 9 rats in normal control and 18 rats in diabetic groups. Diabetic
rats were fedwith a high-fat diet (consisting of 50% carbohydrate, 12% protein,
and 38% fat) for 5 wk, followed by intraperitoneal injection with a single low-
dose of streptozotocin (STZ, 25 mg/kg) after 12-h fasting. The normal control
rats were fed with a standard chow diet. Diabetic rats were randomly divided
into two subgroups: vehicle treated and BBR treated (nZ 9 each). Rats were
housed individually inmetabolic cages for 24-h urinary collection at 4-wk inter-
vals. Ratswere sacrificed 20weeks later.Wedetected the kidneyweight index,
24 h urine protein, morphology study, inflammation and fibrosis markers, such
as IkBa, TGFb1, TbRI and Smad7 by realtime-PCR and Western Blot.
Results: (1) Comparedwith normal rats, the diabetic rats showed higher kidney
weight index and 24h urine protein, berberine treatment decreased kidney
weight index and 24 h urine protein. (2) BBR treatment inhibited histological
injury including deposition of extracellular matrix, thickening of glomerular
basement membrane, and tubular atrophy of DN rats. (3) DN rats showed
decreased Smad7 mRNA and protein expression (P < 0.01), increased
TGFb1mRNA (P < 0.05) and TbRI protein expression (P < 0.05); however, BBR
treatment down-regulated TGFb1, TbRI level (P < 0.05), up-regulated Smad7,
IkBa level (P < 0.05).
Conclusion: Berberine has renoprotective effect on a type 2 diabetic rat
model. The mechanism might suppress inflammation and fibrosis via upregu-
lating expression of Smad7.http://dx.doi.org/10.1016/j.hkjn.2015.08.025
0097
Effects of Tangshen Formula on Dihydropteridine Reductase
Transcription
Rongrong Liu, Sifan Sun, Yumin Wen, Hailing Zhao, Haojun Zhang, Ping Li
Institute of Clinical Medical Science, China-Japan Friendship Hospital,
Chaoyang, Beijing, China
Objectives: Tangshen Formula (TSF) is a Chinese herbal medicine used for
DN treatment. In the current study, we aimed to identify the core regulatory
region of QDPR gene promoter. We also studied whether the Tangshen For-
mula could up-regulate QDPR promoter activity in vitro study and to investi-
gate the Tangshen Formula’s mechanism at molecular level.
Results: Identification of core regulatory region in QDPR gene promoter: as
compared with 2092 w 1 fragment, the relative fluorescence intensity of
the deleted fragment 529 w 116 reduced to 1% (P < 0.01), the fragment
which contained 529w 1 kept 64% (P< 0.05). The relative fluorescence in-
tensity of those deleted fragments 529w 429, 428w 250 and 141w
116 were increased (P < 0.01), and the deleted fragment 249w 142 was
decreased (P< 0.05).QDPR gene promoter couldbe recognized as TangshenFor-
mula’s drug targets: LDH experimental data showed that: the suitable Tangshen
Formula’s concentration in cell experiment were 800 g/ml or less. Results
showed that: Tangshen Formula can improve QDPR gene promoter activity.
Tangshen Formula can improve D5’/pGL3, D3/pGL3, D4/pGL3 three recombi-
nant plasmids activity. But comparing with no drug treated group, drug treated
group is no effect on D1-4/pGL3, D1/pGL3, D2/pGL3’s activity (P> 0.01).
Conclusion: Rat QDPR core regulatory region might locate between 529 and
116 where existing putative negative and positive regulatory elements, espe-
cially, existing several Sp1 binding sites. There may be a potential Sp1 binding
sites at 141w 116 which could inhibit the transcriptional activity of the
promoter.
